- Home
- CBZ vs RXRX Comparison
CBZ vs RXRX Comparison
Compare CBZ & RXRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CBZ
- RXRX
- Stock Information
- Founded
- CBZ 1987
- RXRX 2013
- Country
- CBZ United States
- RXRX United States
- Employees
- CBZ N/A
- RXRX N/A
- Industry
- CBZ Business Services
- RXRX Biotechnology: Pharmaceutical Preparations
- Sector
- CBZ Consumer Discretionary
- RXRX Health Care
- Exchange
- CBZ Nasdaq
- RXRX Nasdaq
- Market Cap
- CBZ 2.9B
- RXRX 2.6B
- IPO Year
- CBZ N/A
- RXRX 2021
- Fundamental
- Price
- CBZ $55.00
- RXRX $5.52
- Analyst Decision
- CBZ
- RXRX Buy
- Analyst Count
- CBZ 0
- RXRX 4
- Target Price
- CBZ N/A
- RXRX $7.25
- AVG Volume (30 Days)
- CBZ 584.5K
- RXRX 69.9M
- Earning Date
- CBZ 10-29-2025
- RXRX 11-05-2025
- Dividend Yield
- CBZ N/A
- RXRX N/A
- EPS Growth
- CBZ N/A
- RXRX N/A
- EPS
- CBZ 1.66
- RXRX N/A
- Revenue
- CBZ $2,675,607,000.00
- RXRX $64,596,000.00
- Revenue This Year
- CBZ $56.11
- RXRX $24.17
- Revenue Next Year
- CBZ $6.11
- RXRX $20.96
- P/E Ratio
- CBZ $33.18
- RXRX N/A
- Revenue Growth
- CBZ 59.19
- RXRX 30.14
- 52 Week Low
- CBZ $50.51
- RXRX $3.79
- 52 Week High
- CBZ $90.13
- RXRX $12.36
- Technical
- Relative Strength Index (RSI)
- CBZ 53.24
- RXRX 47.68
- Support Level
- CBZ $50.80
- RXRX $5.58
- Resistance Level
- CBZ $56.41
- RXRX $6.50
- Average True Range (ATR)
- CBZ 1.87
- RXRX 0.57
- MACD
- CBZ 0.29
- RXRX -0.08
- Stochastic Oscillator
- CBZ 74.96
- RXRX 21.33
About CBZ CBIZ Inc.
CBIZ Inc through its subsidiaries provides professional services advisors to middle-market businesses and organizations nationwide. Its business units have been aggregated into three practice groups: Financial Services, Benefits and Insurance Services, and National Practices. The company provides its services to various industries such as Banking & Financial Services, Commercial Real Estate, Construction, Health Care Manufacturing & Distribution NFP & Education, Private Client Services, Professional Services, Public Sector, and Technology & Life Sciences. It derives the majority of its revenues from the Financial Services segment and geographically from the United States.
About RXRX Recursion Pharmaceuticals Inc.
Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery.